Your Guide to Psychedelics

Gain access to the psychedelic industry’s most robust platform for free.

Join over 3,000 community members

Researchers

Founders

Investors

Therapists

Activists

Find the Psychedelic Courses That Can Launch Your Career

Therapists and sitters are needed to lead the growth of the psychedelic-assisted therapy that is slated to help millions.

Access and Inclusion in Psychedelic Treatment

Psychedelic-assisted therapy is making its way through the established medical system’s approval process and moving towards becoming an available treatment...

Psychedelics

Poetry, Symbols, and Story in Psychedelic Therapy

“And as imagination bodies forth the forms of things unknown, the poet’s pen turns them to shapes and gives to...

Psilocybin-Assisted Therapy: Part 2

In this course trainees receive instruction in psilocybin administration, integration, and group formats for psychedelic facilitation. Trainees are encouraged to...

Psilocybin

Community Psilocybin Harm Reduction Course

Community Psilocybin Harm Reduction Course. In this training course you will learn the benefits of harm reduction and how harm...

Psilocybin

Skylight Psychedelics Ketamine-Assisted Therapy Training + Psilocybin Training/Harm Reduction Course

Ketamine-Assisted Therapy Training PLUS Psilocybin-Assisted Therapy/Harm Reduction

Psilocybin Ketamine

Skylight Psychedelics Ketamine-Assisted Therapy Training Course

A comprehensive course for licensed therapists & providers.

Ketamine

Skylight Psychedelics Psilocybin-Assisted Therapy Training Course: The Comprehensive Harm Reduction Guide from the Underground

The Comprehensive Harm Reduction Guide from the Underground. This course is most comprehensive guide available of its kind. Designed by...

Psilocybin

Microdosing

A proven science-based process to enhance emotional balance, holistic wellness, and peak performance. Unleash your potential with the transformational power...

Psychedelics

View All Courses

Become 'Brain Healthy'

We're creating a world where every human can be more well through stronger access to critical health data.

Explore the Latest Psychedelic Research

Ketamine use in current clinical practice

… named S- and R-ketamine, with each racemate … -ketamine compared with S(+)-ketamine 2 . Several animal studies have shown that the clearance and volume of distribution of ketamine …

Ketamine

Increased global integration in the brain after psilocybin therapy for depression

… of psilocybin on brain function in two clinical trials of depression. The first was an open-label trial of orally administered psilocybin (10 … controlled trial comparing psilocybin therapy with …

Psilocybin

Rediscovering psilocybin as an antidepressive treatment strategy

… psilocybin over the period of the last 20 years. Despite the promising progress in understanding the mechanisms of psilocybin, … treatment effect sizes for psilocybin as an antidepressant. …

Psilocybin

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

… Pooled analysis of six phase 2 trials of MDMA-assisted therapy for PTSD have … of MDMA-assisted therapy in individuals with severe PTSD. Participants were given three doses of …

MDMA

Browse Psychedelics Data

Need Psychedelics Research Done for Your Organization?

Find Legal Psychedelic Therapy and Experiences

Browse through and connect with thousands of vetted practitioners currently serving people like you.

Use Neuly Care

Participate in a Clinical Trial

Find and enroll in active programs taking place around the world.

Browse Clinical Trials

Stay Informed on Psychedelic Companies

View Public Company Index

Add your Listing to Neuly

Neuly is constantly being updated, and we'd love to add your data!

Get Started

From News to Neuly

Written by Psychedelic Invest • 21 hours ago

Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024

VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian...

DMT

Written by Psychedelic Invest • 21 hours ago

atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression

NEW YORK and BERLIN, April 24, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform...

Written by Psychedelic Invest • 21 hours ago

MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry

VANCOUVER – MindBio Therapeutics Corp. (CSE: MBIO) (Frankfurt: WF6), (the ‘Company’ or ‘MindBio’), a clinical stage biopharma company uniquely pioneering novel treatments for psychiatric conditions...

Written by Psychedelic Invest • 1 day ago

Red Light Holland Initiates Psilocybin Extraction Phase with PharmAla Following Successful Testing and Preparation by CCrest Labs

Toronto, Ontario–(Newsfile Corp. – April 23, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland”), a company engaged in...

Psilocybin MDMA

Written by Psychedelic Invest • 1 day ago

Silo Pharma Announces Positive Results for Intranasal PTSD Treatment

SARASOTA, FL, April 23, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing...

Written by Psychedelic Invest • 1 day ago

Legal Battle Intensifies: The Fight for Psilocybin Use in Terminal Care

The ongoing legal battle between a doctor and the U.S. Drug Enforcement Administration (DEA) over the use of psychedelics, specifically psilocybin, for medical purposes is...

Psilocybin